Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Quiles

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Semergen|April 23, 2016
[Secondary prevention of osteoporotic fractures. How well are we doing?]G Kyriakos, A Vidal-Casariego, L V Quiles-Sánchez, et al.
Current Cardiology Reviews|June 5, 2019
Cardiovascular and Renal Outcomes of Incretin-based Therapies: A Review of Recent Clinical TrialsGeorgios Kyriakos, Lourdes V Quiles-Sanchez, Anna Garmpi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Transfer Learning with CNN Models for Brain-Machine Interfaces to command lower-limb exoskeletons: A Solution for Limited Data<sup></sup>L Ferrero, V Quiles, P Soriano-Segura, et al.
Current Cardiology Reviews|August 1, 2019
SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL StudyGeorgios Kyriakos, Lourdes V Quiles-Sanchez, Anna Garmpi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 25, 2016
Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF GuidelinesG Kyriakos, A Vidal-Casariesgo, L V Quiles-Sánchez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Semergen|April 23, 2016
[Secondary prevention of osteoporotic fractures. How well are we doing?]G Kyriakos, A Vidal-Casariego, L V Quiles-Sánchez, et al.
Current Cardiology Reviews|June 5, 2019
Cardiovascular and Renal Outcomes of Incretin-based Therapies: A Review of Recent Clinical TrialsGeorgios Kyriakos, Lourdes V Quiles-Sanchez, Anna Garmpi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Transfer Learning with CNN Models for Brain-Machine Interfaces to command lower-limb exoskeletons: A Solution for Limited Data<sup></sup>L Ferrero, V Quiles, P Soriano-Segura, et al.
Current Cardiology Reviews|August 1, 2019
SGLT2 Inhibitors and Cardiovascular Outcomes: Do they Differ or there is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL StudyGeorgios Kyriakos, Lourdes V Quiles-Sanchez, Anna Garmpi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 25, 2016
Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF GuidelinesG Kyriakos, A Vidal-Casariesgo, L V Quiles-Sánchez, et al.
Pageof 1